Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001622627-24-000064
Filing Date
2024-12-02
Accepted
2024-12-02 11:53:07
Documents
2
Group Members
AHARON GILROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 rosalind_nrsx_13d_nov202.htm SC 13D 79195
2 rosalind_nrxs_exa.htm EX-99.A BD-DIR-RESOL 2313
  Complete submission text file 0001622627-24-000064.txt   83233
Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13D

Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Subject) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94262 | Film No.: 241517923
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)